Oxford Genetics Opens New Facility to Support R&D in Cell and Gene Therapy
Oxford Genetics increased its laboratory space to 5700 sq. ft. with a move to a new location at Oxford Science Park.
On Oct. 19, 2016, Oxford Genetics announced that it has moved operations to a new laboratory in the Oxford Science Park. The company, which specializes in DNA design, protein expression optimization, and cell-line development is moving from its previous location at Begbroke Science Park to the Medawar Centre. This move increases Oxford Genetics laboratory space to 5700 sq ft. The company’s ongoing growth strategy is to expand its operations to support new services for cancer fighting technologies.
In a press announcement, Oxford Genetics said it will use the new location to increase research and development into services to support cell and gene therapy. The new facilities will also include dedicated cell development suites and new robotic platforms for process automation. This will allow Oxford Genetics to scale its services, following an increase in demand.
Source: Oxford Genetics
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
